BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 23440386)

  • 21. Transcriptional silencing of the DLC-1 tumor suppressor gene by epigenetic mechanism in gastric cancer cells.
    Kim TY; Jong HS; Song SH; Dimtchev A; Jeong SJ; Lee JW; Kim TY; Kim NK; Jung M; Bang YJ
    Oncogene; 2003 Jun; 22(25):3943-51. PubMed ID: 12813468
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Unmasking of epigenetically silenced genes reveals DNA promoter methylation and reduced expression of PTCH in breast cancer.
    Wolf I; Bose S; Desmond JC; Lin BT; Williamson EA; Karlan BY; Koeffler HP
    Breast Cancer Res Treat; 2007 Oct; 105(2):139-55. PubMed ID: 17295047
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inactivation of helicase-like transcription factor by promoter hypermethylation in human gastric cancer.
    Leung WK; Yu J; Bai AH; Chan MW; Chan KK; To KF; Chan FK; Ng EK; Chung SC; Sung JJ
    Mol Carcinog; 2003 Jun; 37(2):91-7. PubMed ID: 12766908
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HHIP Overexpression Suppresses Human Gastric Cancer Progression and Metastasis by Reducing Its CpG Island Methylation.
    Song Y; Tu J; Cheng Y; Zhou F; Liu P; Zhou S; Gu Y; Sun Y
    Front Oncol; 2020; 10():1667. PubMed ID: 33415068
    [TBL] [Abstract][Full Text] [Related]  

  • 25. DNA methylation of genes linked with retinoid signaling in gastric carcinoma: expression of the retinoid acid receptor beta, cellular retinol-binding protein 1, and tazarotene-induced gene 1 genes is associated with DNA methylation.
    Shutoh M; Oue N; Aung PP; Noguchi T; Kuraoka K; Nakayama H; Kawahara K; Yasui W
    Cancer; 2005 Oct; 104(8):1609-19. PubMed ID: 16134180
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epigenetic silencing of miRNA-9 is correlated with promoter-proximal CpG island hypermethylation in gastric cancer in vitro and in vivo.
    Li Y; Xu Z; Li B; Zhang Z; Luo H; Wang Y; Lu Z; Wu X
    Int J Oncol; 2014 Dec; 45(6):2576-86. PubMed ID: 25270964
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epigenetic regulation of human hedgehog interacting protein in glioma cell lines and primary tumor samples.
    Shahi MH; Zazpe I; Afzal M; Sinha S; Rebhun RB; Meléndez B; Rey JA; Castresana JS
    Tumour Biol; 2015 Apr; 36(4):2383-91. PubMed ID: 25416442
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of NDRG1 gene promoter methylation with reduced NDRG1 expression in gastric cancer cells and tissue specimens.
    Chang X; Zhang S; Ma J; Li Z; Zhi Y; Chen J; Lu Y; Dai D
    Cell Biochem Biophys; 2013 May; 66(1):93-101. PubMed ID: 23099645
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Frequent silencing of protocadherin 8 by promoter methylation, a candidate tumor suppressor for human gastric cancer.
    Zhang D; Zhao W; Liao X; Bi T; Li H; Che X
    Oncol Rep; 2012 Nov; 28(5):1785-91. PubMed ID: 22941331
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human hedgehog interacting protein expression and promoter methylation in medulloblastoma cell lines and primary tumor samples.
    Shahi MH; Afzal M; Sinha S; Eberhart CG; Rey JA; Fan X; Castresana JS
    J Neurooncol; 2011 Jun; 103(2):287-96. PubMed ID: 20853133
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analysis of genes upregulated by the demethylating agent 5-aza-2'-deoxycytidine in gastric cancer cell lines.
    Mikata R; Yokosuka O; Fukai K; Imazeki F; Arai M; Tada M; Kurihara T; Zhang K; Kanda T; Saisho H
    Int J Cancer; 2006 Oct; 119(7):1616-22. PubMed ID: 16671088
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mediation of the malignant biological characteristics of gastric cancer cells by the methylated CpG islands in RNF180 DNA promoter.
    Deng J; Guo J; Guo X; Hou Y; Xie X; Sun C; Zhang R; Yu X; Liang H
    Oncotarget; 2016 Jul; 7(28):43461-43474. PubMed ID: 27223257
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Promoter methylation of cyclin D2 gene in gastric carcinoma.
    Oshimo Y; Nakayama H; Ito R; Kitadai Y; Yoshida K; Chayama K; Yasui W
    Int J Oncol; 2003 Dec; 23(6):1663-70. PubMed ID: 14612939
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential promoter usages of PTCH1 and down regulation of HHIP are associated with HNSCC progression.
    Chakraborty B; Basu M; Mukhopadhyay D; Alam N; Ghosh S; Dutta S; Panda CK
    Pathol Res Pract; 2022 Apr; 232():153827. PubMed ID: 35276608
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PCDH17 gene promoter demethylation and cell cycle arrest by genistein in gastric cancer.
    Yang Y; Liu J; Li X; Li JC
    Histol Histopathol; 2012 Feb; 27(2):217-24. PubMed ID: 22207556
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CpG island promoter hypermethylation of Ras association domain family 1A gene contributes to gastric carcinogenesis.
    Joo MK; Kim KH; Park JJ; Yoo HS; Choe J; Kim HJ; Lee BJ; Kim JS; Bak YT
    Mol Med Rep; 2015 Apr; 11(4):3039-46. PubMed ID: 25483734
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Co-expression of laminin β3 and γ2 chains and epigenetic inactivation of laminin α3 chain in gastric cancer.
    Ii M; Yamamoto H; Taniguchi H; Adachi Y; Nakazawa M; Ohashi H; Tanuma T; Sukawa Y; Suzuki H; Sasaki S; Imai K; Shinomura Y
    Int J Oncol; 2011 Sep; 39(3):593-9. PubMed ID: 21617852
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epigenetic down-regulation and suppressive role of DCBLD2 in gastric cancer cell proliferation and invasion.
    Kim M; Lee KT; Jang HR; Kim JH; Noh SM; Song KS; Cho JS; Jeong HY; Kim SY; Yoo HS; Kim YS
    Mol Cancer Res; 2008 Feb; 6(2):222-30. PubMed ID: 18314483
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inactivation of O6-methylguanine-DNA methyltransferase by promoter CpG island hypermethylation in gastric cancers.
    Bae SI; Lee HS; Kim SH; Kim WH
    Br J Cancer; 2002 Jun; 86(12):1888-92. PubMed ID: 12085181
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic significance of the methylation of Wnt pathway antagonists-CXXC4, DACT2, and the inhibitors of sonic hedgehog signaling-ZIC1, ZIC4, and HHIP in head and neck squamous cell carcinomas.
    Paluszczak J; Wiśniewska D; Kostrzewska-Poczekaj M; Kiwerska K; Grénman R; Mielcarek-Kuchta D; Jarmuż-Szymczak M
    Clin Oral Investig; 2017 Jun; 21(5):1777-1788. PubMed ID: 27553089
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.